Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma

Patients with advanced head and neck squamous cell carcinoma (HNSCC) usually show a dismal prognosis. It is this worthwhile to develop new, effective therapeutic regimens for these patients, such as molecular targeted therapy, which is promising as an alternative or combination treatment for HNSCC....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Mol Sci
Hlavní autoři: Chou, Ming-Huei, Chuang, Hui-Ching, Lin, Yu-Tsai, Tsai, Ming-Hsien, Kao, Ying-Hsien, Lin, I-Chun, Huang, Tai-Lin, Fang, Fu-Min, Chien, Chih-Yen
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8002492/
https://ncbi.nlm.nih.gov/pubmed/33802643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22063046
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky